
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
Fueled by a desire to boost productivity and collect Meaningful Use incentive funding, a growing number of physicians nationwide are considering EMR solutions. But with hundreds of systems on the market, figuring out where to start can be challenging and finding the right one can be altogether frustrating. This guide, published by Microsoft and gloStream, will help physicians set their buying criteria, ask vendors the right questions and then choose a solution that's reliable, secure and fits their practice's needs.




